HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

HOP-8P

structure in first source

Also Known As:

alpha-Aqua-13,17-bis(1-carboxypropionyl)carbamoylethyl-3,8-bis(1-phenethyloxyethyl)-beta-hydroxy-2,7,12,18-tetramethyl-porphyrinato manganese (III)

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Isogai, Satoshi: 1 article (03/2002)
2.	Kodaira, Nami: 1 article (03/2002)
3.	Masunaga, Hatsuko: 1 article (03/2002)
4.	Nakajima, Susumu: 1 article (03/2002)
5.	Saga, Tsuneo: 1 article (03/2002)
6.	Sakahara, Harumi: 1 article (03/2002)
7.	Sakata, Isao: 1 article (03/2002)
8.	Sugiyama, Masahiro: 1 article (03/2002)
9.	Takeda, Hiroyasu: 1 article (03/2002)
10.	Takehara, Yasuo: 1 article (03/2002)

Related Diseases

1.

Neoplasms (Cancer)

03/01/2002 - "During the 24-h period following contrast administration, HOP-8P was consistently cleared from the circulation, liver, kidneys, and muscle; however, it was progressively accumulated within the tumor. "
03/01/2002 - "Significant enhancement of the transplanted tumor was observed in MR images 24 h after intravenous injection of HOP-8P. "
03/01/2002 - "Tumor-bearing (SCC-VII) mice were imaged using a 1.5T MR imager before and after intravenous administration of 0.1 mmol/kg of HOP-8P. "
03/01/2002 - "HOP-8P is a promising tumor-seeking metalloporphyrin MR contrast agent with a wide imaging window."

Related Drugs and Biologics

1.	Metalloporphyrins
2.	Contrast Media

Related Therapies and Procedures

1.	Intravenous Administration
2.	Intravenous Injections